We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
Peptides shop · Ophthalmic Acid · Reference sheet

Ophthalmic Acid

Reference sheet · Opioid · CPC catalog code OARP-001

Identity

Name
Ophthalmic Acid
Catalog code
OARP-001
Category
Opioid

Physicochemical properties

Sequence
H-gamma-Glu-Abu-Gly-OH (trifluoroacetate salt)

Handling, storage & reconstitution

Upstream storage
CONDITIONS:**-20 ± 5 °C

General guidance for this class

Reference standards in the Opioid class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.

Mechanism & research applications

Ophthalmic Acid sits within the Opioid research class (CPC reference OARP-001). Opioid peptides bind μ, δ, and κ receptors — Gi/o-coupled GPCRs that inhibit adenylate cyclase, activate GIRK channels, and modulate calcium currents to produce analgesia, tolerance, and reward-circuit effects. Investigators typically incorporate Ophthalmic Acid as a reference standard, tool ligand, or substrate in the assay contexts listed above. GTPγS binding, cAMP HTRF, and β-arrestin PathHunter assays.

Studied for

  • Opioid-receptor binding and selectivity profiling
  • β-arrestin recruitment and biased-agonism studies
  • Analgesic mechanism research
  • Tolerance and dependence models

Frequently asked

What is Ophthalmic Acid?

Ophthalmic Acid (CPC catalog code OARP-001) is a synthetic opioid-receptor research peptide in the opioid category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.

What is Ophthalmic Acid studied for?

Published and internal research programs use Ophthalmic Acid as a reference standard in opioid workflows — for example, opioid-receptor binding and selectivity profiling and β-arrestin recruitment and biased-agonism studies. Human clinical evidence is not established.

Is Ophthalmic Acid FDA-approved for human use?

No. Ophthalmic Acid is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.

How is Ophthalmic Acid typically used in the lab?

In a opioid workflow, Ophthalmic Acid is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. GTPγS binding, cAMP HTRF, and β-arrestin PathHunter assays.

Sources

View full product page →Back to catalog

Related peptides in Opioid

Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.

Met-Enkephalin
Dynorphin B (1-9)
Dynorphin A (1-17)
beta-Endorphin, rat
Research use only. The peptides referenced on this page are supplied to qualified laboratories for in-vitro or non-human research. They are not drugs, foods, cosmetics, or dietary supplements, are not for human consumption, and are not intended to diagnose, treat, cure, or prevent any disease. Physicochemical values shown here are transcribed from the cited upstream reference sheet(s); confirm with your own certificate of analysis before use.
Ask Dot